Mayne Pharma Group Ltd

Mayne Pharma Group Ltd: ASX stock swings, a $394 M market cap, and a focus on oral generics amid earnings woes – what investors need to know.

Mayne Pharma Group Ltd, a leading Australian pharmaceutical company, has solidified its position in the market through its focus on branded generics, specialty generics, and active pharmaceutical ingredients, and is poised for further growth and inn…